Blog
RSS FeedPosted by Michael Wonder on 12 May 2016
Decision to list bedaquiline (Sirturo) and siltuximab (Sylvant) for rare disorders
12 May 2016 - PHARMAC is pleased to announce the approval of an agreement with Janssen-Cilag for the listing of bedaquiline ...
Posted by Michael Wonder on 11 May 2016
Statement from the Panel for the Review of Pharmacy Remuneration and Regulation
12 May 2016 - On 9 May 2016, the Australian Government went into ‘caretaker’ mode. After consultation by the Secretariat with the ...
Posted by Michael Wonder on 11 May 2016
NICE backs NHS use of Benlysta, five years after EU nod
11 May 2016 - The first new drug for patients with lupus in more than 50 years could soon be available ...
Posted by Michael Wonder on 09 May 2016
Changes needed to selection of PBS cancer medicines: experts
9 May 2016 - A leading cancer expert says there needs to be a change to the way cancer drugs are ...
Posted by Michael Wonder on 09 May 2016
SMC - May 2016 decisions
9 May 2016 - The SMC has today published advice accepting three new medicines for routine use in NHS Scotland. ...
Posted by Michael Wonder on 09 May 2016
NICE backs use of AbbVie's Humira for hidradenitis suppurativa
9 May 2016 - Final draft guidance not in accordance with HTA agencies in France & Australia. ...
Posted by Michael Wonder on 09 May 2016
Cancer patient pays $5,000 every two weeks for treatment costing others just $6.20
9 May 2016 - At the age of 36, Danielle Tindle has been given an ultimatum — your money or your ...
Posted by Michael Wonder on 09 May 2016
Updated treatment algorithm for the treatment of HER2+ metastatic breast cancer
1 May 2016 - The PBAC treatment algorithm for anti-HER2 therapies for treating metastatic breast cancer has been updated to reflect ...
Posted by Michael Wonder on 07 May 2016
Pharmaceutical Benefits Advisory Committee Guidelines review
6 May 2016 - The public consultation processes on the draft revised PBAC Guidelines (Version 5.0) and the assessment of co-dependent ...
Posted by Michael Wonder on 07 May 2016
NICE draft guidance recommends new drugs for cholesterol disorder
5 May 2016 - NICE has today published final draft guidance recommending 2 new treatment options for some people who have ...
Posted by Michael Wonder on 05 May 2016
Request for proposal - supply of anti-vascular endothelial growth factor agents
5 May 2016 - PHARMAC invites proposals for the supply of anti-vascular endothelial growth factor agents in New Zealand. ...
Posted by Michael Wonder on 05 May 2016
Agenda for the 11 May 2016 TC meeting
5 May 2016 - The Transparency Commission will consider the reimbursement of golimumab (Simponi), metyrapone (Metyrapone HRA Pharma) and tiotropium bromide ...
Posted by Michael Wonder on 05 May 2016
Proposal to widen funded access to temozolomide for treatment of neuroendocrine tumours and high grade gliomas
4 May 2016 - As part of PHARMAC’s 2015/16 annual Invitation to Tender, PHARMAC is proposing to widen access to fully-funded ...
Posted by Michael Wonder on 05 May 2016
Proposal to widen access to rituximab to include children with nephrotic syndrome
4 May 2016 - PHARMAC is seeking feedback on a proposal to amend the funding restrictions for rituximab in DHB hospitals. ...
Posted by Michael Wonder on 04 May 2016
'It's a very good start' – funding boost for Pharmac welcomed, but is it enough?
5 May 2016 - A top health expert has praised the Government's multi-million dollar funding boost to its pharmaceutical agency Pharmac, ...